Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method.

Journal: Scientific reports
Published Date:

Abstract

We evaluate the diagnostic performance of deep learning artificial intelligence (AI) for bladder cancer, which used white-light images (WLIs) and narrow-band images, and tumor grade prediction of AI based on tumor color using the red/green/blue (RGB) method. This retrospective study analyzed 10,991 cystoscopic images of suspicious bladder tumors using a mask region-based convolutional neural network with a ResNeXt-101-32 × 8d-FPN backbone. The diagnostic performance of AI was evaluated by calculating sensitivity, specificity, and diagnostic accuracy, and its ability to detect cancers was investigated using the dice score coefficient (DSC). Using the support vector machine model, we analyzed differences in tumor colors according to tumor grade using the RGB method. The sensitivity, specificity, diagnostic accuracy and DSC of AI were 95.0%, 93.7%, 94.1% and 74.7%. In WLIs, there were differences in red and blue values according to tumor grade (p < 0.001). According to the average RGB value, the performance was ≥ 98% for the diagnosis of benign vs. low-and high-grade tumors using WLIs and > 90% for the diagnosis of chronic non-specific inflammation vs. carcinoma in situ using WLIs. The diagnostic performance of the AI-assisted diagnosis was of high quality, and the AI could distinguish the tumor grade based on tumor color.

Authors

  • Jeong Woo Yoo
    Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kyo Chul Koo
    Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Byung Ha Chung
  • Sang Yeop Baek
    Infinyx Corporation, Daegu, Republic of Korea.
  • Su Jin Lee
    Nuclear Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kyu Hong Park
    Infinyx Corporation, Daegu, Republic of Korea.
  • Kwang Suk Lee
    Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.